Mainstream

Secarna pharmaceuticals and vect horus announce research collaboration to advance systemic delivery of rna targeted therapeutics for cns disorders

Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted Therapeutics for CNS Disorders

Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted Therapeutics for CNS Disorders

The partnership combines Secarna’s OligoCreator ® technology with Vect-Horus’ VECTrans ® platform to enable systemic delivery of…Read More

You might also be interested in reading U.S. copper tariffs seen launching final rush to get metal across the border.

July 10, 2025
In Mainstream